Jun30
Listening Session: Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition
As part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First, the Federal Trade Commission and the Department of Justice, along with...